Neomycin Impurity 7 | CAS 108864-61-5 - Request Quote
Neomycin Impurity 7
| SZ CAT No: | SZ-N033022 |
| CAS No | 108864-61-5 |
| Mol.F. | C6H14N2O4 |
| Mol.Wt. | 178.2 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 1609090-99-4 (XHCl salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Neomycin Impurity 7 is chemically (3R,4R,5S,6R)-3-amino-6-(aminomethyl)tetrahydro-2H-pyran-2,4,5-triol. Neomycin Impurity 7 is supplied with detailed characterization data compliant with regulatory guideline. Neomycin Impurity 7 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Neomycin sulfate.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 108864-61-5
Purchase 108864-61-5
Order 108864-61-5
Enquire 108864-61-5
price of 108864-61-5
108864-61-5 Supplier
108864-61-5 Manufacturer
108864-61-5 Exporter
buy high quality Neomycin Impurity 7
Purchase Neomycin Impurity 7
Neomycin Impurity 7 suppliers
Neomycin Impurity 7 manufacturers
Neomycin Impurity 7 price
Order Neomycin Impurity 7
Enquire Neomycin Impurity 7
Neomycin Impurity 7 cost
Neomycin Impurity 7 Supplier
Neomycin Impurity 7 Distributor
Neomycin Impurity 7 for Method Validation
Neomycin sulfate Reference Standard
Neomycin Impurity 7 for ANDA Filing
Neomycin Impurity 7 for Forced Degradation Studies
Neomycin Impurity 7 Identification Standards
Neomycin Impurity 7 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.